Freezing prostate tumors shows promise in cancer control study
NCT ID NCT03503643
First seen May 24, 2026 · Last updated Jun 16, 2026 · Updated 4 times
Summary
This study looked at 354 men with prostate cancer who chose to freeze half of their prostate gland (hemi-gland cryoablation) to kill cancer cells. The goal was to see how well this treatment controls the cancer and affects quality of life, like urinary function. All patients had advanced MRI and targeted biopsies before treatment to precisely locate the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.